ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 2094

$878K Total Retail Price of All Prescriptions

Rank: 145 out of 2094

413 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 9,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
PROAIR HFA 527 366 1 45
SIMVASTATIN 511 388 2 1
OMEPRAZOLE 400 323 3 4
METFORMIN HCL 379 279 4 8
DIOVAN 351 256 5 13
AMLODIPINE BESYLATE 343 263 6 2
METOPROLOL SUCCINATE 300 208 7 9
MELOXICAM 270 234 8 49
ATORVASTATIN CALCIUM 259 156 9 5
LOSARTAN POTASSIUM 244 183 10 17
LISINOPRIL 239 198 11 7
LEVOTHYROXINE SODIUM 237 185 12 3
DONEPEZIL HCL 211 196 13 20
NEXIUM 204 152 14 16
CLOPIDOGREL 198 163 15 22
ALENDRONATE SODIUM 198 166 15 30
NAPROXEN 177 117 17 84
ADVAIR DISKUS 165 94 18 36
AZITHROMYCIN 165 95 18 27
PREDNISONE 161 82 20 54
FUROSEMIDE 159 136 21 6
ZOLPIDEM TARTRATE 151 91 22 14
PLAVIX 147 109 23 38
GABAPENTIN 142 88 24 23
CLOTRIMAZOLE-BETAMETHASONE 140 119 25 91
CRESTOR 129 108 26 15
TAMSULOSIN HCL 128 126 27 29
EXFORGE 124 111 28 105
GLIPIZIDE XL 123 102 29 122
GLIPIZIDE ER 122 95 30 126
NABUMETONE 114 79 31 203
TRAMADOL HCL 109 97 32 33
MECLIZINE HCL 106 90 33 103
METOPROLOL TARTRATE 106 86 33 10
DIOVAN HCT 106 68 33 28
AMLODIPINE BESYLATE-BENAZEPRIL 102 55 36 58
CARVEDILOL 96 64 37 19
LIPITOR 94 61 38 39
JANUVIA 93 69 39 35
CELEBREX 89 83 40 74
GLIMEPIRIDE 75 61 41 31
ATENOLOL 72 65 42 21
SPIRIVA 72 51 42 60
ENALAPRIL MALEATE 71 56 44 25
FLUTICASONE PROPIONATE 67 41 45 41
VENTOLIN HFA 67 24 45 132
SERTRALINE HCL 66 37 47 26
ACTOS 66 48 47 112
SINGULAIR 64 26 49 64
CLONIDINE HCL 61 59 50 62
HUMULIN 70-30 61 24 50 279
INSULIN SYRINGE 58 34 52 143
BENICAR 58 46 52 108
HYDROCODONE-ACETAMINOPHEN 56 27 S3 54 42
GLIPIZIDE 55 44 55 82
LEVOCETIRIZINE DIHYDROCHLORIDE 55 39 55 169
LABETALOL HCL 55 29 55 215
DILTIAZEM 24HR ER 53 43 58 176
LEVOFLOXACIN 52 31 59 70
DETROL LA 52 52 59 233
IBUPROFEN 51 17 61 73
PAROXETINE HCL 51 15 61 77
ATELVIA 51 35 61 135
PATANOL 51 38 61 198
CYMBALTA 50 34 65 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.